Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen, Inc. | 1.46% | 243.82 | 1.3% | $795.90m | |
| IMMU | Immunomedics, Inc. | 0.07% | 85.36 | 11.0% | $697.18m | |
| MRNA | Moderna, Inc. | 6.60% | 69.47 | 0.0% | $666.49m | |
| NVAX | Novavax, Inc. | 10.86% | 113.56 | 96.5% | $629.01m | |
| ILMN | Illumina, Inc. | 4.74% | 299.89 | 3.5% | $582.79m | |
| GILD | Gilead Sciences, Inc. | 0.00% | 62.25 | 1.0% | $574.11m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 2.98% | 574.06 | 2.7% | $443.39m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 1.92% | 268.18 | 1.9% | $340.86m | |
| BIIB | Biogen, Inc. | 1.20% | 273.28 | 1.6% | $334.97m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 2.15% | 114.43 | 2.0% | $285.22m | |
| EXAS | EXACT Sciences Corp. | 3.60% | 97.70 | 20.7% | $257.29m | |
| SRNE | Sorrento Therapeutics, Inc. | 4.84% | 9.64 | 1.5% | $240.99m | |
| VXRT | Vaxart, Inc. | 7.40% | 7.40 | 0.0% | $213.88m | |
| SGEN | Seattle Genetics, Inc. | 3.08% | 184.95 | 6.0% | $212.14m | |
| MNTA | Momenta Pharmaceuticals, Inc. | 0.02% | 52.40 | 3.0% | $193.58m |
Company Profile
vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. Its products target the treatment of central nervous system disorders, diabetes and metabolic disorders, inflammation, and cancer. It offers Azeliragon, TTP399, TTP273, HPP593, HPP737, and Nrf2/Bach1 program. The company was founded on April 2, 2015 and is headquartered in High Point, NC.